Stoneridge (SRI) Misses Q2 EPS by 14c, Updates FY Guidance
Tweet
Share
E-mailGet Alerts SRI Hot Sheet
Price: $15.35 +0.66%
Financial Fact:
Selling, general and administrative: 27.82M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Selling, general and administrative: 27.82M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Stoneridge (NYSE: SRI) reported Q2 EPS of ($0.14), $0.14 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $191.3 million versus the consensus estimate of $185.91 million.
GUIDANCE:
Stoneridge sees FY2021 EPS of $0.20-$0.30, versus the consensus of $0.45. Stoneridge sees FY2021 revenue of $770-790 million, versus the consensus of $772 million.
For earnings history and earnings-related data on Stoneridge (SRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Minerals Technologies (MTX) Tops Q1 EPS by 16c
- Utah Medical Products (UTMD) Reports Q1 EPS of $1.10
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
